Active — Not RecruitingNot Applicable

Ablation of Renal Masses Outcomes Registry (ARMOR): Ablation Procedure and Quality of Life Assessment

United States294 participantsStarted 2013-06

Plain-language summary

The purpose of this study is to better understand how effective ablation is for destroying tumor cells in the kidney and whether quality of life is improved for patients. Participation in ARMOR may involve retrospective data collection only, combined retrospective and prospective data collection, or prospective data collection

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Retrospective enrollment: \- Patients having undergone percutaneous, open or laparoscopic energy ablation of a renal mass. Prospective enrollment: \- Patients scheduled to undergo, rather than having undergone, percutaneous, open or laparoscopic energy ablation of a renal mass. Exclusion Criteria: * Patients not having undergone, or considered candidates for percutaneous, open or laparoscopic energy ablation of a renal mass * Non-English speaking patients * Patients under the age of 18.

What they're measuring

assess renal ablation outcomes

Timeframe: 5 years

Trial details

NCT IDNCT01888198

SponsorMemorial Sloan Kettering Cancer Center

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-06

View on ClinicalTrials.gov More Renal Cancer trials